|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Narcolepsy | |||||
| 2 | More general conditions related to this trial | ||||
| Disorders of Excessive Somnolence | |||||
| Dyssomnias | |||||
| Mental Disorders | |||||
| Nervous System Diseases | |||||
| Sleep Disorders | |||||
| Sleep Disorders, Intrinsic | |||||
| 3 | Interventions listed in this trial | ||||
| JNJ-17216498 | |||||
| 4 | Sponsors listed in this trial | ||||
| Alza Corporation, DE, USA | |||||